With the US Food and Drug Administration's (FDA) approval process for genetically modified salmon crawling along on a seemingly indefinite timeline, RTTNews reports AquaBounty Technologies' first half loss has widened to $3.5 million, from $2.1m last year. [...]
Want to keep reading?
Sign up for a trial to have full access to our articles for 7 days!
Have an account? Log in here:
Enter the email address associated with your account. We'll send you instructions to reset your password.
We’ve sent a link to to change your password.
Please check your inbox to reset your password securely and easily.
redirecting...
